Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases
AssigneeMedizinische Hochschule Hannover
InventorsKai Christoph Wollert, Mortimer Korf-Klingebiel
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedizinische Hochschule Hannover
InventorsKai Christoph Wollert, Mortimer Korf-Klingebiel
Estimating the term…
The present invention relates to proteins comprising amino acid sequences encoded by nucleic acids derived from the human chromosomal region C19Orf10 termed Factor1 and/or C19Orf63 termed Factor 2 for the use in enhancing proliferation and/or healing and/or inhibiting apoptosis of none-transformed tissue or none-transformed cell or inhibitors thereof. The invention further relates to the use of inhibitors of factor1 and factor 2 for medical use, preferably for use in treating or preventing a disease in which angiogenesis contributes to disease development or progression.
A method for treating myocardial infarction in a subject, comprising:
A method of treating myocardial infarction in a subject, comprising:
A method for treating a disease or disorder excluding myocardial infarction, comprising administering to a subject in need thereof an amount effective to treat the disease of a protein comprising the amino acid sequence according to SEQ ID NO:
Dependencies are inferred from the claim text.